Study Links Prenatal Exposure to Air Pollution to Negative Impact on Infants’ Heart Rate Response to Stress
A mother’s exposure to particulate air pollution during pregnancy is associated with reduced cardiac response to stress in six-month-old infants, according to Mount Sinai research published in Environmental Health Perspectives in October. This study is the first to find that particulate air pollution exposure in utero can affect heart rate variability, which is a known risk factor for health issues.
Variability in how the heart rate responds to stressful experiences is essential for maintaining optimal functioning of the cardiovascular, respiratory, and digestive systems and also is central to emotional well-being and resilience to stress over one’s lifetime. Decreased heart rate variability, as observed in this study, is a known risk factor for mental and physical health problems in later life. Air pollution’s negative effect on heart rate variability has previously been found to lead to medical and psychological conditions such as heart disease, asthma, allergies, and mood or behavioral disorders in studies of older children, adolescents, and adults.
Mount Sinai researchers studied 237 Boston-based mothers and their infants and used satellite data and air pollution monitors to determine the level of particulate air pollution the mothers were exposed to during pregnancy. The air pollution levels in this study were similar to levels experienced by the general U.S. population.
By studying the babies’ heart rate and respiration at age six months, researchers found that the higher the level of the mother’s exposure to air pollution in pregnancy, the less variability in the infant’s heart rate in response to a stress challenge.
“These findings, in combination with increasing worldwide exposure to particulate air pollution, highlight the importance of examining early-life exposure to air pollution in relation to negative medical, developmental, and psychological outcomes,” said senior author Rosalind Wright, MD, MPH, Dean for Translational Biomedical Research, and Professor of Pediatrics, Environmental Medicine and Public Health, and Medicine (Pulmonary, Critical Care and Sleep Medicine), at the Icahn School of Medicine at Mount Sinai. “A critical step in identifying children at risk for costly chronic disorders is identifying exposures that lead to early vulnerability.”
“Identifying exposures that disrupt key processes such as heart rate response will lead to prevention strategies early in life when they can have the greatest impact. Specifically, these findings support individual-level and policy-level action to reduce exposure to particulate air pollution exposure during pregnancy,” said the study’s first author, Whitney Cowell, PhD, a postdoctoral fellow in Environmental Medicine and Public Health at the Icahn School of Medicine.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.
